Therapeutic compositions
US8278292B2 · kind B2 · utility
9Cited by
0References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 18, 2006 |
| Grant date | Oct 2, 2012 |
| Priority date | — |
| Expiry date | Feb 20, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Ingenol angelate is a potent anticancer agent, and can be stabilized by dissolving it in an aprotic solvent in the presence of an acidic buffer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.